Heterocyclic modulators of gpr119 for treatment of disease

作者: Stewart A. Noble , Nicholas D. Smith , Celine Bonnefous , Mehmet Kahraman , Joseph E. Payne

DOI:

关键词:

摘要: The present invention relates to compounds and methods which may be useful as inhibitors of GPR119 for the treatment or prevention metabolic, cardiovascular, metabolic diseases.

参考文章(13)
Teresa Sandvall, Michael Weber, Peter Brandt, Gary Johansson, Bjoern M. Nilsson, Lars Johansson, Tobias Koolmeister, Pyrimidine compounds for treating gpr119 related disorders ,(2007)
Andrew J. Carpenter, Gregory Peckham, Jing Fang, Chemical Compounds and Uses ,(2009)
Lisa Sarah Bertram, Matthew Colin Thor Fyfe, Martin James Procter, Geoffrey Martyn Williams, Heterocyclic gpcr agonists ,(2009)
Graeme Semple, Beatriz Fioravanti, Guillherme Pereira, Imelda Calderon, Jane Uy, Karoline Choi, Yifeng Xiong, Albert Ren, Michael Morgan, Vibha Dave, William Thomsen, David J. Unett, Charles Xing, Stuart Bossie, Chris Carroll, Zhi-Liang Chu, Andrew J. Grottick, Erin K. Hauser, James Leonard, Robert M. Jones, Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119. Journal of Medicinal Chemistry. ,vol. 51, pp. 5172- 5175 ,(2008) , 10.1021/JM8006867
Masayuki Yamashita, Tsuneo Yasuma, Masahiro Itou, Nobuyuki Negoro, Fused cyclic compounds ,(2007)